Pioneering therapeutics agians
atherosclerosis
|

About
Invites Phagogen Unreal Projects

Since its establishment in July 2024, phagogen has been continuously conducting research and development through startup activities and securing R&D projects.
파고젠은 24년 7월 설립 이후 창업 및 r&d 과제 수주 등을 통해 지속적인 연구 개발을 진행하고 있습니다.

R&D

Science and Technology

Efferocytosis control technology or materials may provide hope for the treatment of arteriosclerosis

Efferocytosis

Efferocytosis is the process by which dying cells are removed by phagocytic cells such as macrophages.

Atherosclerosis

Atherosclerosis is a condition in which the walls of the arteries become thickened and narrowed due to the buildup of fatty deposits, cholesterol, and other substances